Neurocrine Biosciences names Eiry W. Roberts chief medical officer, replacing Sanjay Keswani
Bitget2026/09/28 20:06- Neurocrine Biosciences named Eiry W. Roberts as chief medical officer, effective immediately.
- Sanjay Keswani will leave the company under a mutual agreement.
- Roberts previously served as chief medical officer from 2018 to 2025, most recently acting as a strategic advisor.
- She spent 26 years at Eli Lilly, including as vice president of research and development.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Besent “Extinguishes Fire”: Rising US Treasury yields are a global phenomenon, dismisses concerns over AI bubble
U.S. Treasury Secretary Janet Yellen defended the rise in U.S. Treasury yields, stating that this increase is a global phenomenon rather than unique to the United States, and does not warrant excessive concern. She partially attributed inflationary pressures to higher oil prices caused by the Iran conflict, and expects the energy shock to subside as hostilities ease. Yellen refuted the notion of an AI bubble, arguing that investments by major tech companies are grounded in solid business logic.
Bitcoin Crash Warning Goes Viral as X Post Flags Benner Cycle
"New High" WLD rises to $0.6177, reaching a nearly 3-month peak
Crypto prices
More
